Royal Bank of Canada’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35K | Sell |
1,438
-66,556
| -98% | -$1.58M | ﹤0.01% | 5662 |
|
|
2025
Q4 | $1.69M | Sell |
67,994
-87,891
| -56% | -$2.33M | ﹤0.01% | 3249 |
|
|
2025
Q3 | $4.42M | Sell |
155,885
-161,212
| -51% | -$4.37M | ﹤0.01% | 2770 |
|
|
2025
Q2 | $7.89M | Buy |
317,097
+38,478
| +14% | +$1.08M | ﹤0.01% | 2210 |
|
|
2025
Q1 | $8.64M | Buy |
278,619
+17,028
| +7% | +$567K | ﹤0.01% | 1858 |
|
|
2024
Q4 | $8.25M | Buy |
261,591
+7,020
| +3% | +$333K | ﹤0.01% | 1939 |
|
|
2024
Q3 | $14.8M | Sell |
254,571
-8,742
| -3% | -$430K | ﹤0.01% | 1536 |
|
|
2024
Q2 | $10.7M | Buy |
263,313
+60,174
| +30% | +$2.39M | ﹤0.01% | 1634 |
|
|
2024
Q1 | $8.53M | Sell |
203,139
-15,499
| -7% | -$605K | ﹤0.01% | 1780 |
|
|
2023
Q4 | $8.37M | Buy |
218,638
+17,778
| +9% | +$592K | ﹤0.01% | 1841 |
|
|
2023
Q3 | $6.2M | Buy |
200,860
+5,027
| +3% | +$173K | ﹤0.01% | 1935 |
|
|
2023
Q2 | $6.19M | Buy |
195,833
+14,581
| +8% | +$500K | ﹤0.01% | 1938 |
|
|
2023
Q1 | $6.61M | Sell |
181,252
-2,929
| -2% | -$103K | ﹤0.01% | 1868 |
|
|
2022
Q4 | $5.45M | Buy |
184,181
+56,688
| +44% | +$1.82M | ﹤0.01% | 2065 |
|
|
2022
Q3 | $4.97M | Buy |
127,493
+26,411
| +26% | +$1.21M | ﹤0.01% | 2082 |
|
|
2022
Q2 | $3.9M | Buy |
101,082
+40,199
| +66% | +$1.53M | ﹤0.01% | 2314 |
|
|
2022
Q1 | $2.95M | Sell |
60,883
-131
| -0.2% | -$6.76K | ﹤0.01% | 2700 |
|
|
2021
Q4 | $4.48M | Sell |
61,014
-28,227
| -32% | -$2.32M | ﹤0.01% | 2453 |
|
|
2021
Q3 | $8.13M | Sell |
89,241
-14,483
| -14% | -$1.23M | ﹤0.01% | 1972 |
|
|
2021
Q2 | $6.51M | Sell |
103,724
-3,123
| -3% | -$115K | ﹤0.01% | 2132 |
|
|
2021
Q1 | $2.9M | Buy |
106,847
+104,444
| +4,346% | +$2.51M | ﹤0.01% | 2710 |
|
|
2020
Q4 | $44K | Buy |
2,403
+324
| +16% | +$5.82K | ﹤0.01% | 5718 |
|
|
2020
Q3 | $37K | Buy |
2,079
+24
| +1% | +$414 | ﹤0.01% | 5477 |
|
|
2020
Q2 | $34K | Sell |
2,055
-248
| -11% | -$3.9K | ﹤0.01% | 5383 |
|
|
2020
Q1 | $30K | Sell |
2,303
-212
| -8% | -$3.46K | ﹤0.01% | 5396 |
|
|
2019
Q4 | $46K | Buy |
2,515
+185
| +8% | +$3.07K | ﹤0.01% | 5500 |
|
|
2019
Q3 | $41K | Hold |
2,330
| – | – | ﹤0.01% | 5209 |
|
|
2019
Q2 | $39K | Hold |
2,330
| – | – | ﹤0.01% | 5403 |
|
|
2019
Q1 | $43K | Sell |
2,330
-21
| -0.9% | -$403 | ﹤0.01% | 5249 |
|
|
2018
Q4 | $46K | Sell |
2,351
-179
| -7% | -$3.35K | ﹤0.01% | 5151 |
|
|
2018
Q3 | $55K | Buy |
2,530
+179
| +8% | +$3.77K | ﹤0.01% | 5188 |
|
|
2018
Q2 | $61K | Buy |
2,351
+21
| +0.9% | +$360 | ﹤0.01% | 5066 |
|
|
2018
Q1 | $37K | Hold |
2,330
| – | – | ﹤0.01% | 5194 |
|
|
2017
Q4 | $56K | Buy |
+2,330
| New | +$46.8K | ﹤0.01% | 5117 |
|
Other funds holding ASTH
VPM
3C
VCM
6CM
Royal Bank of Canada's ASTH Position: Q1 2026 in Review
Royal Bank of Canada reduced its Astrana Health (ASTH) stake by 98% in Q1 2026, selling an estimated $1.58M and leaving 1,438 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #5662.
Royal Bank of Canada first reported a position in ASTH in Q4 2017 and has held it in 34 quarters since. The position peaked at $14.8M in Q3 2024. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.
- Royal Bank of Canada held 1,438 shares of Astrana Health worth $35K as of Q1 2026.
- Royal Bank of Canada sold 66,556 Astrana Health shares in Q1 2026, an estimated $1.58M.
- Astrana Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5662 holding.
- Royal Bank of Canada first reported a position in Astrana Health in Q4 2017 and has held it in 34 quarters since.
- Royal Bank of Canada's Astrana Health position peaked at $14.8M in Q3 2024.
- 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.